Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults

Atopic Dermatitis: Phase 3 double-blinded study, 8-week study with potential rollover into an open label extension. Topical cream. Currently enrolling males/females 2-17 years old with atopic dermatitis (AD), also known as eczema Eczema is an inflammatory skin condition that can occur repeatedly. AD often causes itching and burning, skin flaking, and red bumps that can crust and open up. The purpose of this study is to find out if the investigational study medicine, tapinarof cream, can help with the treatment of AD.

For this study there are up to 7 visits and 2 phone calls over a period of 13 weeks. Subjects will use a topical cream every day for 8 weeks and will come to the study site for questionnaires, physical exams, blood draws, and urine testing at multiple visits.

Compensation for travel and expenses may be available

Andrea Zaenglein
Samantha Gettle - at or 717-531-5136

Younger than 18 years old
This study is NOT accepting healthy volunteers
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
AD present for at least 6 months for ages 6 and above, or 3 months for ages 2 to 5
AD covering between 5% and 35% body surface area
Willing to follow all study guidelines

Exclusion Criteria:
Current or chronic liver disease
Certain treatments for AD are not allowed; coordinator will discuss specific treatments
Skin Conditions
I'm interested
Share via email
See this study on
Show 1 location

Study Locations

Hide all locations
Location Contacts
Hershey, PA ,